{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:46:32Z","timestamp":1785714392571,"version":"3.56.0"},"reference-count":51,"publisher":"Pharmaceutical Society of Japan","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1248\/bpb.b16-00093","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T22:14:51Z","timestamp":1480544091000},"page":"1912-1921","source":"Crossref","is-referenced-by-count":5,"title":["Regulation of Matrix Metalloproteinases-2 and -9 Gene Expression in Cultured Human Fetal Membrane Cells by Influenza Virus Infection"],"prefix":"10.1248","volume":"39","author":[{"given":"Noboru","family":"Uchide","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University"},{"name":"Department of Clinical Molecular Genetics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Obatake","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Sadanari","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsugiya","family":"Murayama","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Ohyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Molecular Genetics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Lavery JP. Appendages of the placenta. The human placenta<\/i> (Lavery JP ed.), Aspen Publishers Inc., Maryland, pp. 257\u2013279 (1987)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Malak TM, Bell SC. Structural characteristics of term human fetal membranes: a novel zone of extreme morphological alteration within the rupture site. Br. J. Obstet. Gynaecol.<\/i>, 101<\/b>, 375\u2013386 (1994).","DOI":"10.1111\/j.1471-0528.1994.tb11908.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Parry S, Strauss JF 3rd. Premature rupture of the fetal membranes. N. Engl. J. Med.<\/i>, 338<\/b>, 663\u2013670 (1998).","DOI":"10.1056\/NEJM199803053381006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Romero R, Espinoza J, Gon\u00e7alves LF, Kusanovic JP, Friel LA, Nien JK. Inflammation in preterm and term labour and delivery. Semin. Fetal Neonatal Med.<\/i>, 11<\/b>, 317\u2013326 (2006).","DOI":"10.1016\/j.siny.2006.05.001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Uchide N, Ohyama K, Bessho T, Takeichi M, Toyoda H. Possible roles of proinflammatory and chemoattractive cytokines produced by human fetal membrane cells in the pathology of adverse pregnancy outcomes associated with influenza virus infection. Mediators Inflamm.<\/i>, 2012<\/b>, 270670 (2012).","DOI":"10.1155\/2012\/270670"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am. J. Obstet. Gynecol.<\/i>, 205<\/b>, 10\u201318 (2011).","DOI":"10.1016\/j.ajog.2010.12.033"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lieberman RW, Bagdasarian N, Thomas D, Van De Ven C. Seasonal influenza A (H1N1) infection in early pregnancy and second trimester fetal demise. Emerg. Infect. Dis.<\/i>, 17<\/b>, 107\u2013109 (2011).","DOI":"10.3201\/eid1701.091895"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) McGregor JA, Burns JC, Levin MJ, Burlington B, Meiklejohn G. Transplacental passage of influenza A\/Bangkok (H3N2) mimicking amniotic fluid infection syndrome. Am. J. Obstet. Gynecol.<\/i>, 149<\/b>, 856\u2013859 (1984).","DOI":"10.1016\/0002-9378(84)90604-5"},{"key":"9","unstructured":"9) Mel\u2019nikova VF, Tsinzerling AV, Aksenov OA, Vydumkina SP, Kalinina NA. Involvement of the afterbirth in influenza. Arkh. Patol.<\/i>, 49<\/b>, 19\u201325 (1987)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Gu J, Xie Z, Gao Z, Liu J, Korteweg C, Ye J, Lau LT, Lu J, Gao Z, Zhang B, McNutt MA, Lu M, Anderson VM, Gong E, Yu AC, Lipkin WI. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet<\/i>, 370<\/b>, 1137\u20131145 (2007).","DOI":"10.1016\/S0140-6736(07)61515-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Xu L, Bao L, Deng W, Qin C. Highly pathogenic avian influenza H5N1 virus could partly be evacuated by pregnant BALB\/c mouse during abortion or preterm delivery. Virol. J.<\/i>, 8<\/b>, 342 (2011).","DOI":"10.1186\/1743-422X-8-342"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Uchide N, Ohyama K, Bessho T, Yuan B, Yamakawa T. Apoptosis in cultured human fetal membrane cells infected with influenza virus. Biol. Pharm. Bull.<\/i>, 25<\/b>, 109\u2013114 (2002).","DOI":"10.1248\/bpb.25.109"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Uchide N, Ohyama K, Yuan B, Sano T, Bessho T, Yamakawa T. Differential mRNA expression of inflammatory cytokines in cultured human fetal membrane cells responding to influenza virus infection. Biol. Pharm. Bull.<\/i>, 25<\/b>, 239\u2013243 (2002).","DOI":"10.1248\/bpb.25.239"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Uchide N, Suzuki A, Ohyama K, Bessho T, Toyoda H. Secretion of bioactive interleukin-6 and tumor necrosis factor-\u03b1 proteins from primary cultured human fetal membrane chorion cells infected with influenza virus. Placenta<\/i>, 27<\/b>, 678\u2013690 (2006).","DOI":"10.1016\/j.placenta.2005.06.004"},{"key":"15","unstructured":"15) Uchide N, Ohyama K, Bessho T, Toyoda H. Induction of pro-inflammatory cytokine gene expression and apoptosis in human chorion cells of fetal membranes by influenza virus infection: possible implications for maintenance and interruption of pregnancy during infection. Med. Sci. Monit.<\/i>, 11<\/b>, RA7\u2013RA16 (2005)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Menon R, Fortunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Pract. Res. Clin. Obstet. Gynaecol.<\/i>, 21<\/b>, 467\u2013478 (2007).","DOI":"10.1016\/j.bpobgyn.2007.01.008"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, Bermejo L, Iwata K, Strauss JF 3rd. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am. J. Obstet. Gynecol.<\/i>, 174<\/b>, 1371\u20131376 (1996).","DOI":"10.1016\/S0002-9378(96)70687-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Fortunato SJ, Menon R, Lombardi SJ. Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane. Am. J. Obstet. Gynecol.<\/i>, 177<\/b>, 731\u2013741 (1997).","DOI":"10.1016\/S0002-9378(97)70260-6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Menon R, Fortunato SJ. The role of matrix degrading enzymes and apoptosis in rupture of membranes. J. Soc. Gynecol. Investig.<\/i>, 11<\/b>, 427\u2013437 (2004).","DOI":"10.1016\/j.jsgi.2004.04.001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Geng J, Huang C, Jiang S. Roles and regulation of the matrix metalloproteinase system in parturition. Mol. Reprod. Dev.<\/i>, 83<\/b>, 276\u2013286 (2016).","DOI":"10.1002\/mrd.22626"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Weiss A, Goldman S, Shalev E. The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front. Biosci.<\/i>, 12<\/b>, 649\u2013659 (2007).","DOI":"10.2741\/2089"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Fortunato SJ, Menon R. IL-1\u03b2 is a better inducer of apoptosis in human fetal membranes than IL-6. Placenta<\/i>, 24<\/b>, 922\u2013928 (2003).","DOI":"10.1016\/S0143-4004(03)00160-7"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Menon R, Lombardi SJ, Fortunato SJ. TNF-\u03b1 promotes caspase activation and apoptosis in human fetal membranes. J. Assist. Reprod. Genet.<\/i>, 19<\/b>, 201\u2013204 (2002).","DOI":"10.1023\/A:1014898130008"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kumar D, Fung W, Moore RM, Pandey V, Fox J, Stetzer B, Mansour JM, Mercer BM, Redline RW, Moore JJ. Proinflammatory cytokines found in amniotic fluid induce collagen remodeling, apoptosis, and biophysical weakening of cultured human fetal membranes. Biol. Reprod.<\/i>, 74<\/b>, 29\u201334 (2006).","DOI":"10.1095\/biolreprod.105.045328"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Yeo SJ, Kim SJ, Kim JH, Lee HJ, Kook YH. Influenza A virus infection modulates the expression of type IV collagenase in epithelial cells. Arch. Virol.<\/i>, 144<\/b>, 1361\u20131370 (1999).","DOI":"10.1007\/s007050050592"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Wang S, Quang Le T, Chida J, Cisse Y, Yano M, Kido H. Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in influenza A virus infection. J. Med. Invest.<\/i>, 57<\/b>, 26\u201334 (2010).","DOI":"10.2152\/jmi.57.26"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Shapiro S, Khodalev O, Bitterman H, Auslender R, Lahat N. Different activation forms of MMP-2 oppositely affect the fate of endothelial cells. Am. J. Physiol. Cell Physiol.<\/i>, 298<\/b>, C942\u2013C951 (2010).","DOI":"10.1152\/ajpcell.00305.2009"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Sun K, Qu X, Gao L, Myatt L. Dexamethasone fails to inhibit the induction of cytosolic phospholipase A2<\/sub> expression by interleukin-1\u03b2 in cultured primary human amnion fibroblasts. Placenta<\/i>, 27<\/b>, 164\u2013170 (2006).","DOI":"10.1016\/j.placenta.2005.03.004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Steel JH, O\u2019donoghue K, Kennea NL, Sullivan MH, Edwards AD. Maternal origin of inflammatory leukocytes in preterm fetal membranes, shown by fluorescence in situ<\/i> hybridisation. Placenta<\/i>, 26<\/b>, 672\u2013677 (2005).","DOI":"10.1016\/j.placenta.2004.10.003"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Gibb W, Sun M. Cellular specificity of interleukin-1\u03b2-stimulated expression of type-2 prostaglandin H synthase in human amnion cell cultures. Biol. Reprod.<\/i>, 59<\/b>, 1139\u20131142 (1998).","DOI":"10.1095\/biolreprod59.5.1139"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) McParland PC, Taylor DJ, Bell SC. Myofibroblast differentiation in the connective tissues of the amnion and chorion of term human fetal membranes-implications for fetal membrane rupture and labour. Placenta<\/i>, 21<\/b>, 44\u201353 (2000).","DOI":"10.1053\/plac.1999.0439"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Kim SS, Romero R, Kim JS, Abbas A, Espinoza J, Kusanovic JP, Hassan S, Yoon BH, Kim CJ. Coexpression of myofibroblast and macrophage markers: novel evidence for an in vivo<\/i> plasticity of chorioamniotic mesodermal cells of the human placenta. Lab. Invest.<\/i>, 88<\/b>, 365\u2013374 (2008).","DOI":"10.1038\/labinvest.3700749"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Sato T, Iwai M, Sakai T, Sato H, Seiki M, Mori Y, Ito A. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. Br. J. Cancer<\/i>, 80<\/b>, 1137\u20131143 (1999).","DOI":"10.1038\/sj.bjc.6690477"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Ogawa K, Chen F, Kuang C, Chen Y. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-\u03b2 is mediated by a nuclear factor-\u03baB site. Biochem. J.<\/i>, 381<\/b>, 413\u2013422 (2004).","DOI":"10.1042\/BJ20040058"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Yu H, Pan C, Zhao S, Wang Z, Zhang H, Wu W. Resveratrol inhibits tumor necrosis factor-\u03b1-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Biomed. Pharmacother.<\/i>, 62<\/b>, 366\u2013372 (2008).","DOI":"10.1016\/j.biopha.2007.09.006"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer<\/i>, 9<\/b>, 20 (2009).","DOI":"10.1186\/1471-2407-9-20"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J. Clin. Invest.<\/i>, 119<\/b>, 1420\u20131428 (2009).","DOI":"10.1172\/JCI39104"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Alcaraz A, Mrowiec A, Insausti CL, Garc\u00eda-Vizca\u00edno EM, Ruiz-Canada C, L\u00f3pez-Mart\u00ednez MC, Moraleda JM, Nicol\u00e1s FJ. Autocrine TGF-\u03b2 induces epithelial to mesenchymal transition in human amniotic epithelial cells. Cell Transplant.<\/i>, 22<\/b>, 1351\u20131367 (2013).","DOI":"10.3727\/096368912X657387"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Uchide N, Ohyama K, Bessho T, Toyoda H. Lactate dehydrogenase leakage as a marker for apoptotic cell degradation induced by influenza virus infection in human fetal membrane cells. Intervirology<\/i>, 52<\/b>, 164\u2013173 (2009).","DOI":"10.1159\/000224644"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Garcia-Lopez G, Vadillo-Ortega F, Merchant-Larios H, Maida-Claros R, Osorio M, Soriano-Becerril D, Flores-Herrera H, Beltran-Montoya J, Garfias-Becerra Y, Zaga-Clavellina V. Evidence of in vitro<\/i> differential secretion of 72 and 92\u2009kDa type IV collagenases after selective exposure to lipopolysaccharide in human fetal membranes. Mol. Hum. Reprod.<\/i>, 13<\/b>, 409\u2013418 (2007).","DOI":"10.1093\/molehr\/gam025"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Zaga-Clavellina V, Garcia-Lopez G, Flores-Pliego A, Merchant-Larios H, Vadillo-Ortega F. In vitro<\/i> secretion and activity profiles of matrix metalloproteinases, MMP-9 and MMP-2, in human term extra-placental membranes after exposure to Escherichia coli.<\/i> Reprod. Biol. Endocrinol.<\/i>, 9<\/b>, 13 (2011).","DOI":"10.1186\/1477-7827-9-13"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Tao L, Suhua C, Juanjuan C, Zongzhi Y, Juan X, Dandan Z. In vitro<\/i> study on human cytomegalovirus affecting early pregnancy villous EVT\u2019s invasion function. Virol. J.<\/i>, 8<\/b>, 114 (2011).","DOI":"10.1186\/1743-422X-8-114"},{"key":"43","unstructured":"43) Vadillo-Ortega F, Gonz\u00e1lez-Avila G, Furth EE, Lei H, Muschel RJ, Stetler-Stevenson WG, Strauss JF 3rd. 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am. J. Pathol.<\/i>, 146<\/b>, 148\u2013156 (1995)."},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Athayde N, Edwin SS, Romero R, Gomez R, Maymon E, Pacora P, Menon R. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am. J. Obstet. Gynecol.<\/i>, 179<\/b>, 1248\u20131253 (1998).","DOI":"10.1016\/S0002-9378(98)70141-3"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Ota A, Yonemoto H, Someya A, Itoh S, Kinoshita K, Nagaoka I. Changes in matrix metalloproteinase 2 activities in amniochorions during premature rupture of membranes. J. Soc. Gynecol. Investig.<\/i>, 13<\/b>, 592\u2013597 (2006).","DOI":"10.1016\/j.jsgi.2006.10.001"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Oger S, M\u00e9hats C, Dallot E, Cabrol D, Leroy MJ. Evidence for a role of phosphodiesterase 4 in lipopolysaccharide-stimulated prostaglandin E2<\/sub> production and matrix metalloproteinase-9 activity in human amniochorionic membranes. J. Immunol.<\/i>, 174<\/b>, 8082\u20138089 (2005).","DOI":"10.4049\/jimmunol.174.12.8082"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Lappas M, Permezel M, Rice GE. 15-Deoxy-\u220612,14<\/sup>-prostaglandin J2<\/sub> and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. Placenta<\/i>, 27<\/b>, 1060\u20131072 (2006).","DOI":"10.1016\/j.placenta.2005.11.009"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Moore RM, Novak JB, Kumar D, Mansour JM, Mercer BM, Moore JJ. Alpha-lipoic acid inhibits tumor necrosis factor-induced remodeling and weakening of human fetal membranes. Biol. Reprod.<\/i>, 80<\/b>, 781\u2013787 (2009).","DOI":"10.1095\/biolreprod.108.073205"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Izumi-Yoneda N, Toda A, Okabe M, Koike C, Takashima S, Yoshida T, Konishi I, Saito S, Nikaido T. Alpha 1 antitrypsin activity is decreased in human amnion in premature rupture of the fetal membranes. Mol. Hum. Reprod.<\/i>, 15<\/b>, 49\u201357 (2009).","DOI":"10.1093\/molehr\/gan071"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Mano Y, Shibata K, Sumigama S, Hayakawa H, Ino K, Yamamoto E, Kajiyama H, Nawa A, Kikkawa F. Tocilizumab inhibits interleukin-6-mediated matrix metalloproteinase-2 and -9 secretions from human amnion cells in preterm premature rupture of membranes. Gynecol. Obstet. Invest.<\/i>, 68<\/b>, 145\u2013153 (2009).","DOI":"10.1159\/000229021"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Levkau B, Kenagy RD, Karsan A, Weitkamp B, Clowes AW, Ross R, Raines EW. Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells. Cell Death Differ.<\/i>, 9<\/b>, 1360\u20131367 (2002).","DOI":"10.1038\/sj.cdd.4401106"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/12\/39_b16-00093\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:54:42Z","timestamp":1498366482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/12\/39_b16-00093\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00093","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}